Sevdenur Keskin

Sevdenur Keskin practices at UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences.

Sevdenur Keskin's NPI, 1972008431, was assigned on March 27, 2018. Sevdenur Keskin holds Arkansas license E-16611.

Sevdenur Keskin's primary practice is UAMS Medical Center, at 4301 West Markham Street Mail Slot 612, Little Rock, AR 72205 in Pulaski County. The practice phone is (501) 686-5000.

Sevdenur Keskin's primary practice is UAMS Medical Center in Little Rock, Arkansas, part of University of Arkansas for Medical Sciences. Sevdenur Keskin is also affiliated with Arkansas Children's Hospital. The medical group on file is UAMS - University of Arkansas for Medical Sciences. Dmand AI also links Sevdenur Keskin to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sevdenur Keskin practices, 2 sites in all. Vendor and product names are available with a free account.

Allergy and immunology is Sevdenur Keskin's primary specialty in the NPI Registry, under taxonomy code 207K00000X. Sevdenur Keskin is licensed in Arkansas.

CMS data shows 65 Medicare services from Sevdenur Keskin across 3 procedure codes in 2024, for 41 Medicare patients. Medicare paid $3,370 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 41 Medicare patients who saw Sevdenur Keskin in 2024. The largest group is 65 to 74, with 21 patients. 75% of them have arthritis, and 75% have high blood pressure. Their average risk score is 1.70, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sevdenur Keskin's median patient age at 46, with 69% women.

In 2024, Sevdenur Keskin wrote 120 Medicare Part D claims for 38 patients. 70% of them were for generic drugs. CMS names the drug for 50 of them, across 3 drugs with 11 or more claims each, at $702 in total drug cost. In 2023, CMS named 62 claims across 4 drugs.

Sevdenur Keskin accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sevdenur Keskin as offering telehealth.

Dmand AI links 5 papers to Sevdenur Keskin, published from 2019 to 2024. 2024 was the busiest year, with 2. The most frequent topics are Body Patterning, Gene Expression Regulation, Developmental and Phenotype. Sevdenur Keskin's most frequent co-authors are Jocelyn Celestin, MD, Akilah Andrea Jefferson, MD and Yosif Nidal Pak, DO.